Taiwan FDA registration f6db107e6f5e89bdadff85faca0d40af
ADVOCATE Redi-Code+ Blood Glucose Monitoring System
TW: 艾德福康血糖測試系統
Taiwan·Risk Class 2·MD·BROADMASTER BIOTECH. CORP.·Registered Jun 02, 2015 – Jun 02, 2020CancelledRegistration details
- Analysis ID
- f6db107e6f5e89bdadff85faca0d40af
- License Form
- Ministry of Health Medical Device Manufacturing No. 004933
Company information
- Manufacturer
- BROADMASTER BIOTECH. CORP.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- BROADMASTER BIOTECH. CORP.
Product details
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1345 Glucose Test System
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Jun 02, 2015
- Expiry Date
- Jun 02, 2020
- Cancellation Date
- Aug 05, 2022
Cancellation information
- Status
- Logged out
- Reason
- 未展延而逾期者
About this record
Access comprehensive regulatory information for ADVOCATE Redi-Code+ Blood Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f6db107e6f5e89bdadff85faca0d40af and manufactured by BROADMASTER BIOTECH. CORP.. The authorized representative in Taiwan is BROADMASTER BIOTECH. CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices